// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Atrial fibrillation is associated with long-term mortality in patients undergoing surgical aortic valve replacement

Mohamed Farag - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Accurate detection of af using a smartphone remains uncertain: a systematic review and meta-analysis

Simrat Gill - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Defining endothelial CD47 signalling in heart failure

Zoe Haines - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Hydrogen peroxide

Novel pericardial left ventricular assist device (PAL-VAD) assessment via large animal and cadaveric models

Amila Diluka Premawardhana - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Esmolol

Systematic review and meta-analysis comparing bilateral versus single internal thoracic artery grafts in patients with diabetes and obesity undergoing coronary artery bypass graft surgery

Marcus Flather - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Using smarthphone applications to target poor cardiac medication adherance

Sharan Syam - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Influence of diabetes and obesity on mortality and sternal wound complications after coronary artery bypass graft surgery: ten-year follow-up from the arterial revascularisation trial

Marcus Flather - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

E Machine learning wall thickness measurement in hypertrophic cardiomyopathy exceeds performance of world experts

Joao B Augusto - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

B Oxidized PKARIα protects against ischemia-reperfusion injury by inhibiting lysosomal-triggered calcium release

Jillian N Simon - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

C In-vivo grafting of large engineered heart tissue patches for cardiac repair

Richard J Jabbour - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

D Diabetes mellitus generates the substrate for atrial fibrillation by causing a localised conduction block

Klemen Ziberna - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Arrhythmia

Streptozotocin

A The endothelium as a paracrine modulator of adipose function: a role for endothelial IGF-1R in the setting of nutritional obesity

Natalie J Haywood - British Cardiovascular Society (BCS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Hereditary alpha‐tryptasemia due to a TPSAB1 gene duplication associated with multifocal sclerotic bone disease

Elkhalifa S - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Zoledronic acid

Over or under‐detection? A comparison of exercise and eucapnic voluntary hyperpnoea in the evaluation of exercise‐induced bronchoconstriction

Jackson A - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Serology with specific IgE in children with asthma could lead to substantial cost savings for the NHS: A population‐based simulation study

Mascialino B - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A novel asthma monitoring device studying symptomatic asthmatics during the first month of corticosteroid treatment

Brooks LP - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

IL‐9 expression in ocular allergy

Eskandarpour M - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

lonomycin

Homozygous status for CHI3L1 variant is associated with decreased prescribing of inhaled corticosteroids

Soares P - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Two‐site immunoassays for the quantification of major egg allergens ovomucoid (Gal D 1) and ovalbumin (Gal D 2)

Bermingham M - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adherence to the STROBE checklist in articles published in EAACI journals: A systematic review

Wiehn E - European Academy of Allergy and Clinical Immunology (EAACI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved